Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 27; no. 7; pp. 1063 - 1067
• Main Authors: Inada, Makoto, Ishikane, Masahiro, Terada, Mari, Matsunaga, Akihiro, Maeda, Kenji, Tsuchiya, Kiyoto, Miura, Kenji, Sairenji, Yu, Kinoshita, Noriko, Ujiie, Mugen, Kutsuna, Satoshi, Ishizaka, Yukihito, Mitsuya, Hiroaki, Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.07.2021; Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd
• Subjects: Anti-Spike protein IgG antibody; COVID-19; Neutralizing antibody; Original; Re-infection; SARS-CoV-2; COVID-19; SARS-CoV-2; Re-infection; Anti-Spike protein IgG antibody; Neutralizing antibody

“Re-infection” with COVID-19 is a growing concern; re-infection cases have reported worldwide. However, the clinical characteristics of SARS-CoV-2 re-infection, including the levels and role of anti-SARS-CoV-2 Spike protein IgG antibodies and the half-maximal concentration (IC50) of neutralizing ant...